Regulation of cholesterol biosynthetic pathway in patients with the Smith–Lemli–Opitz syndrome
✍ Scribed by M. Honda; G. S. Tint; A. Honda; G. Salen; S. Shefer; A. K. Batta; Y. Matsuzaki; N. Tanaka
- Book ID
- 110226932
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 88 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We describe the clinical effects of cholesterol supplementation in 6 children with the RSH-"Smith-Lemli-Opitz" syndrome (SLOS). The children ranged in age from birth to 11 years at the onset of therapy, with pretreatment cholesterol levels ranging from 8 to 62 mg/dl. Clinical benefits of therapy wer
Smith-Lemli-Opitz (SLO) affected children have multiple congenital physical and mental abnormalities; photosensitivity to ultraviolet A (UVA) has recently become a recognized feature. We present a patient with SLO and prominent photosensitivity in whom detailed phototesting has been performed at bas